<DOC>
	<DOCNO>NCT00539929</DOCNO>
	<brief_summary>This double-blind , multicenter study assess efficacy safety E6201 topical administration pre-identified marker lesion adult subject chronic plaque type psoriasis . Treatment duration 8 week , follow 4-week period without treatment . Pharmacokinetic sample obtain pre-and post treatment .</brief_summary>
	<brief_title>Paired-Comparison Study Evaluating Efficacy Safety E6201 Versus Vehicle Treatment Plaque-Type Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>INCLUSION CRITERIA : Males females 18 year old clinical diagnosis mildtomoderate plaquetype psoriasis â‰¥12 month prior screen Female participant postmenopausal &gt; 1 year surgically sterile Two representative similar target lesion condition , 1525 centimeter square ( cm^2 ) , 50 cm^2 surface area Target lesion severity score 48 scale 0 12 , , opinion Investigator , 0 equal evidence disease 12 equal severe induration , erythema , scaling , pruritus Prescription medication , applicable , chronic condition allow must stable regimen prior study ; also applicable dietary supplement overthecounter ( OTC ) drug Participants able willing give inform consent EXCLUSION CRITERIA Use , concomitant , topical treatment psoriasis , exclude emollient Use , concomitant , systemic treatment psoriasis , include ultraviolet radiation ( UVR ) light Evidence significant hepatic , gastrointestinal , renal , respiratory , endocrine , hematological , neurological , psychiatric , musculoskeletal , rheumatologic , cardiovascular system abnormality Evidence clinically significant deviation normal respect medical history , physical examination , vital sign , 12lead electrocardiogram ( ECG ) , clinical laboratory determination . If participant abnormal clinical laboratory test find meet specify criterion , participant retested repeat blood draw clinical laboratory assessment . If abnormal test finding confirm , participant exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>